PLx Pharma Inc.
PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio—
52W High$3.41
52W Low$0.009
PLx Pharma Inc.（PLXP）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PLXP · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($46.13M) | ($15.21M) | ($20.50M) | $0.90M | ($15.35M) |
| Depreciation & Amort. | $0.21M | $0.42M | $0.16M | $0.20M | $0.03M |
| Stock-Based Comp. | $2.88M | $1.29M | $0.88M | $0.00M | $0.00M |
| Change in Working Capital | $5.41M | ($0.49M) | $0.87M | $0.25M | ($2.70M) |
| Net Cash from Operations | ($32.12M) | ($12.24M) | ($12.66M) | ($9.50M) | ($13.31M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.10M) | ($0.24M) | ($0.65M) | ($0.54M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.10M | ($0.10M) | ($0.23M) | ($0.65M) | $11.24M |
| Financing Activities | |||||
| Common Stock Repurchased | $8.04M | $1.74M | $13.75M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | $78.97M | $20.79M | $12.64M | $0.00M | $26.41M |
| Free Cash Flow | |||||
| Free Cash Flow | ($32.12M) | ($12.35M) | ($12.90M) | ($10.15M) | ($13.84M) |
| FCF Margin %(computed) | -391.30% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解PLx Pharma Inc.
关于PLx Pharma Inc.（PLXP）现金流量表
PLx Pharma Inc. 2021财年经营活动现金流($0.03B)，自由现金流($0.03B)（FCF利润率-391.30%），资本支出$0.00B。
常见问题
PLXP · 4 问PLx Pharma Inc. 2021财年自由现金流($0.03B)，同比down160.2%。
PLXP free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10